Journal article
An association of Ephedra use with psychosis and autonomic hyperactivity
Annals of clinical psychiatry, Vol.16(3), pp.167-169
07/2004
DOI: 10.1080/10401230490487043
PMID: 15517849
Abstract
Ephedra extract is used in a number of dietary supplements taken for a variety of purposes including weight loss. Although recent events have led to calls for Ephedra to be removed from the market and the FDA has had over 18,000 adverse event reports, newspaper reports cite only a few instances of clearly associated adverse events associated with Ephedra use. In this communication, we review the literature and present a case report of Ephedra use associated with the onset of psychosis and autonomic hyperactivity after administration of risperidone. We conclude that the behavioral effects of Ephedra are a public health concern.
Details
- Title: Subtitle
- An association of Ephedra use with psychosis and autonomic hyperactivity
- Creators
- Robert Philibert - Department of Psychiatry and Neuroscience Program, The University of Iowa, Iowa City, Iowa 52242-1000, USA. robert-philibert@uiowa.eduJoseph Mac
- Resource Type
- Journal article
- Publication Details
- Annals of clinical psychiatry, Vol.16(3), pp.167-169
- DOI
- 10.1080/10401230490487043
- PMID
- 15517849
- NLM abbreviation
- Ann Clin Psychiatry
- ISSN
- 1040-1237
- eISSN
- 1547-3325
- Publisher
- United States
- Grant note
- K08MH064714 / NIMH NIH HHS
- Language
- English
- Date published
- 07/2004
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Psychiatry; Iowa Neuroscience Institute
- Record Identifier
- 9984003917002771
Metrics
27 Record Views